Effect of evolocumab on fasting and post fat load lipids and lipoproteins in familial dysbetalipoproteinemia
Open Access
- 29 October 2022
- journal article
- research article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 17 (1) , 112-123
Abstract
No abstract availableKeywords
Funding Information
- Radboud Universitair Medisch Centrum
- Amgen BV
This publication has 40 references indexed in Scilit:
- Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Can Mediate Degradation of the Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1)PLOS ONE, 2013
- Proteolytic Processing of Angiopoietin-like Protein 4 by Proprotein Convertases Modulates Its Inhibitory Effects on Lipoprotein Lipase ActivityJournal of Biological Chemistry, 2011
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007
- Screening for Dysbetalipoproteinemia by Plasma Cholesterol and Apolipoprotein B ConcentrationsClinical Chemistry, 2005
- Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery diseaseJACC, 2005
- NARC-1/PCSK9 and Its Natural MutantsJournal of Biological Chemistry, 2004
- Post-transcriptional Regulation of Low Density Lipoprotein Receptor Protein by Proprotein Convertase Subtilisin/Kexin Type 9a in Mouse LiverJournal of Biological Chemistry, 2004
- Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.Journal of Clinical Investigation, 1987
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955